Thyrocare Technology Q2 Results FY26: Q2 PAT Rises 80.76% to ₹47 Crore; Revenue Up 22.03% YoY

Wed Oct 15 2025

Click and Sign Up to Get Live Updates on Q2 Results

Thyrocare Technology Q2 Results FY26: Thyrocare Technology posted its Q2 results on 14th October 2025. The company posted robust numbers, with Q2 PAT standing at ₹47 crores against revenue of ₹216 crores. During Q2 FY26, the profit increase of the company was recorded at 80.76% YoY, and the revenue increase for the same period was 22.03%.

Table of Contents

Thyrocare Technology Q2 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

Particulars	Quarter Ended
Particulars	30-09-2025	30-09-2024
Revenue from Operations	₹216	₹177
Profit Before Tax (PBT)	₹62	₹37
Profit After Tax (PAT)	₹47	₹26

(Figures in crores)

Thyrocare Technology Q2 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

Particulars	Quarter Ended
Particulars	30-09-2025	30-09-2024
Revenue from Operations	₹202	₹163
Profit Before Tax (PBT)	₹60	₹40
Profit After Tax (PAT)	₹43	₹29

(Figures in crores)

Thyrocare Technology Q2 Results FY26 Highlights (Q2 FY26 vs FY25)

Thyrocare Technology clocked Q2 FY26 consolidated revenue of ₹216 crores vs ₹177 crores.
On the profit front, Thyrocare Technology earned a consolidated PAT of ₹47 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹26 crore.
As per the consolidated figures, the quarterly PAT of Thyrocare Technology has increased by 80.76%, and revenue has increased by 22.03% YoY.
Thyrocare Technology clocked Q2 FY26 standalone revenue of ₹202 crores vs ₹163 crores.
On the profit front, Thyrocare Technology earned a standalone PAT of ₹43 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹29 crore.
As per the standalone figures, the quarterly PAT of Thyrocare Technology has increased by 48.27%, and revenue has increased by 23.92% YoY.

Thyrocare Technology Share Price Performance

On the opening bell of 15th October 2025, the shares of Thyrocare Technology opened at ₹1,461.10 per share. However, the initial gains have wiped out as of now, and Thyrocare Technology shares are trading at ₹1,255.00 per share, lower than their opening price.

Considering the long-term performance, Thyrocare Technology shares have yielded close to 51.45% returns in the past 1 year, and 5-year returns stand at 23.85%. Over the maximum timeframe, the Thyrocare Technology share provided 100.64% returns to investors.

What Analysts Expect Post Q2 Results?

As Thyrocare Technology has posted robust Q2 results for FY26, analysts are expecting positive trends in its share price. As per the analysts, Thyrocare Technology’ share price could reach ₹1,370.20 per share in the coming year, and in downtrends, the share price could hit the level of ₹1,190.40 per share. However, one must ignore the risk of volatility in the stock market and invest in Thyrocare Technology’ shares after thorough research.

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!